![Ryan Daws](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Daws
Finanzdirektor/CFO bei
ENGENE THERAPEUTICS INC.
Vermögen: - $ am 31.05.2026
Profil
Ryan Daws is currently Chief Financial Officer at enGene Therapeutics, Inc. since 2023.
Former roles include CFO & Head-Business Development at Obsidian Therapeutics, Inc. from 2019 to 2023; Managing Director-Healthcare Investment Banking at Robert W.
Baird & Co., Inc. from 2017 to 2019; Chief Financial Officer at Concert Pharmaceuticals, Inc. from 2014 to 2017; Director at Stifel, Nicolaus & Co., Inc. from 2010 to 2013; Director at Cowen & Co. LLC from 2000 to 2009; and Principal at Aptiv Services US LLC.
Education includes undergraduate studies at the University of South Carolina and an MBA from Darla Moore School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 24.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Ryan Daws
| Unternehmen | Position | Beginn |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Finanzdirektor/CFO | 27.11.2023 |
Ehemalige bekannte Positionen von Ryan Daws
| Unternehmen | Position | Ende |
|---|---|---|
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Finanzdirektor/CFO | 01.11.2023 |
Robert W. Baird & Co., Inc.
 Robert W. Baird & Co., Inc. Investment ManagersFinance Provides financial advisory, wealth, asset management and investment banking services | Corporate Officer/Principal | 01.03.2019 |
| CONCERT PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 15.06.2017 |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01.06.2013 |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Direktor/Vorstandsmitglied | 31.12.2009 |
Ausbildung von Ryan Daws
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Aptiv Services US LLC
 Aptiv Services US LLC Auto Parts: OEMProducer Manufacturing Manufactures automotive components | Producer Manufacturing |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert W. Baird & Co., Inc.
Robert W. Baird & Co., Inc. Investment ManagersFinance Provides financial advisory, wealth, asset management and investment banking services | Finance |
Darla Moore School of Business
 Darla Moore School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
